Sermorelin
Growth Hormone Releasing Peptide - GHRH(1-29) fragment studied for GH-axis research.
Sermorelin is the shortest fully functional fragment of growth-hormone-releasing hormone, studied for its role in stimulating natural GH production.
Sermorelin is the classical GHRH(1-29) fragment and, with a prescription history behind it, serves as a well-understood reference for endogenous GH stimulation. It is often the baseline against which newer GHRH analogs are compared.
Sermorelin specifications
- Sequence
- GHRH(1-29) fragment
- Presentation
- Lyophilised powder
- Documented purity
- 99.57% by HPLC
- Available sizes
- 10mg ($100)
- Archived COA lots
- 2
- Intended use
- Laboratory research use only. Not for human or veterinary use.
Studied pathways
- GHRH receptor - Reference GHRH fragment studied for endogenous GH stimulation.
Reported mechanisms in the literature
- GHRH receptor - The shortest fully functional fragment of growth-hormone-releasing hormone, studied as a reference GHRH agonist for endogenous GH stimulation. (Walker et al.)
Sermorelin frequently asked questions
What is Sermorelin?
The shortest fully functional fragment of growth-hormone-releasing hormone (GHRH 1-29), studied for stimulating natural GH production.
Is Sermorelin approved?
It has a prescription history for a specific indication but is not sold here as a medicine. This material is supplied for laboratory research only.
What is it researched for?
Reference GHRH-receptor activation and endogenous GH stimulation.
Documented to 99.57% purity by HPLC · third-party COA every lot · from $100 · For laboratory research use only.
Related Growth Hormone compounds
- Tesamorelin - GHRH analog studied for growth-hormone-axis research.
- Ipamorelin - Selective GH secretagogue studied for receptor-selective GH release.
- CJC-1295 - GHRH analog studied for sustained GH signalling.